# Centre Hospitalier Universitaire, Amiens: Phase 3 study started recruiting, 182 planned (Intravenous Lidocaine, Laparoscopic Surgery)

**Score:** 60/100

| Field | Value |
|---|---|
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Sponsor type | Academic and hospital |
| Study | Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery |
| NCT ID | NCT07414706 |
| Phase | Phase 3 |
| Status | recruiting |
| Conditions | Intravenous Lidocaine; Laparoscopic Surgery; Post Operative Recovery; Local Anaesthetic Systemic Toxicity |
| Intervention types | drug |
| Target enrollment | 182 |
| Site countries | France |
| Posted | 2026-02-17 |
| Planned start | 2026-09-22 |
| Event | Started recruiting |
| Event date | 2026-09-22 |
| Last update posted | 2026-10-16 |

## Why this score
- Just started recruiting: sites, recruitment and supply are active.
- Phase 3: multi-site, larger budget.
- 182 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07414706). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.